Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India

• Main Authors: Ravikirti (Author), Ranjini Roy (Author), Chandrima Pattadar (Author), Rishav Raj (Author), Neeraj Agarwal (Author), Bijit Biswas (Author), Pramod Kumar Manjhi (Author), Deependra Kumar Rai (Author), Shyama (Author), Anjani Kumar (Author), Asim Sarfaraz (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19)...